Comparative Pharmacology
Head-to-head clinical analysis: DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE versus PATHILON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE versus PATHILON.
DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) vs PATHILON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3) in the gastrointestinal tract, producing antispasmodic effects by reducing smooth muscle contractions.
Anticholinergic agent that competitively inhibits muscarinic acetylcholine receptors, decreasing gastrointestinal motility and gastric acid secretion.
20 mg intramuscularly every 4-6 hours.
1-2 mg orally every 4-6 hours; maximum 12 mg/day. Alternatively, IM: 1-2 mg every 4-6 hours.
None Documented
None Documented
5-8 hours; may be prolonged in elderly or patients with hepatic impairment
Terminal elimination half-life approximately 2-4 hours; may be prolonged in elderly or patients with hepatic/renal impairment.
Renal (approximately 50-80% as unchanged drug and metabolites), biliary/fecal (minor, <10%)
Primarily renal (50-70% as unchanged drug and metabolites); biliary/fecal (20-30%); minor metabolism via hepatic ester hydrolysis.
Category A/B
Category C
Anticholinergic
Anticholinergic